' s response to reviews Title : Healthcare utilization and costs in patients with schizophrenia or bipolar disorder receiving aripiprazole , quetiapine , or ziprasidone at hospital discharge : A retrospective cohort study

[1]  J. Haro,et al.  Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: Results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study , 2011, Psychiatry Research.

[2]  R. Conley,et al.  The cost of relapse and the predictors of relapse in the treatment of schizophrenia , 2010, BMC psychiatry.

[3]  M. Lage,et al.  Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[4]  M. Olfson,et al.  Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia , 2007, Schizophrenia bulletin.

[5]  R. Diamond,et al.  The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with Schizophrenia , 2007, Administration and Policy in Mental Health and Mental Health Services Research.

[6]  D. Harrison,et al.  Impact of atypical antipsychotics on outcomes of care in schizophrenia. , 2005, The American journal of managed care.

[7]  B. Druss,et al.  Relationship of Total Health Care Charges to Selective Serotonin Reuptake Inhibitor Utilization Patterns Including the Length of Antidepressant Therapy Results From a Managed Care Administrative Claims Database , 2005, Journal of managed care pharmacy : JMCP.

[8]  M. Eaddy,et al.  Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. , 2005, Clinical therapeutics.

[9]  P. Lapuerta,et al.  Non-adherence to antipsychotic medication regimens: Associations with resource use and costs , 2004, British Journal of Psychiatry.

[10]  Christian R. Dolder,et al.  Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. , 2004, The American journal of psychiatry.

[11]  P. Thieda,et al.  An economic review of compliance with medication therapy in the treatment of schizophrenia. , 2003, Psychiatric services.

[12]  J. Mccombs,et al.  Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program. , 2002, Journal of affective disorders.